Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic parotitis: not another SPINKosis.

Felix Gundling1, Fabian Reitmeier, Andrea Tannapfel

  • 1Medizinische Klinik und Poliklinik II, Universitatsklinikum Leipzig, Deutschland.

Digestive Diseases (Basel, Switzerland)
|March 9, 2005
PubMed
Summary

The serine protease inhibitor, Kazal type-1 (SPINK1) N34S mutation, previously linked to pancreatitis, was investigated in chronic parotitis cases. This study found no significant association between the SPINK1-N34S mutation and chronic parotitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S2k Guideline Diagnosis and Assessment of Lung Disease Caused by Occupational Silica Dust Exposure (Silicosis) - Clinical Practice Guidelines published by the German Respiratory Society (DGP).

Respiration; international review of thoracic diseases·2026
Same author

Complement mediated thrombotic microangiopathy after liver transplantation in combination with a novel C6 variant of uncertain significance.

Frontiers in immunology·2026
Same author

PSMB8 stratifies therapy response in eosinophilic esophagitis.

Clinical and experimental immunology·2026
Same author

Corrigendum to: "A rare vascular puzzle: Portal hypertension and hepatic lesions" [J Hepatol (2026) 84: e59-61].

Journal of hepatology·2026
Same author

PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancer.

BMC cancer·2026
Same author

[Mesothelioma in situ of the parietal pleura as an occupational disease after exposure to asbestos: a case report of an insured patient with assessment in a social court proceeding].

Pneumologie (Stuttgart, Germany)·2026

Area of Science:

  • Genetics
  • Gastroenterology
  • Otorhinolaryngology

Background:

  • Chronic pancreatitis and parotitis share similarities in causes, pathology, and function.
  • Mutations in the serine protease inhibitor, Kazal type-1 (SPINK1) gene are linked to some chronic pancreatitis cases.
  • The N34S mutation in SPINK1 is a known risk factor for pancreatitis.

Purpose of the Study:

  • To investigate if the pancreatitis-associated N34S mutation of SPINK1 is also a risk factor for chronic parotitis.
  • To determine the prevalence of the SPINK1-N34S mutation in patients with chronic parotitis of unknown etiology.

Main Methods:

  • Reverse-transcriptase polymerase chain reaction (RT-PCR) was employed to analyze SPINK1 gene transcription in parotid gland tissue.
  • Formalin-fixed, paraffin-embedded tissue blocks from 45 patients with chronic parotitis were screened for the SPINK1-N34S mutation.

Related Experiment Videos

  • The mutation frequency in patients was compared to that of 82 healthy blood donors.

    • Main Results:

    • The SPINK1 gene is actively transcribed in the parotid gland.
    • The SPINK1-N34S mutation was found heterozygously in 4.4% (2 out of 45) of chronic parotitis patients.
    • The mutation's prevalence in parotitis patients (3.7% in 82 healthy donors) was not statistically significant (p = 0.83).

    Conclusions:

    • The SPINK1-N34S mutation is not associated with the development of chronic parotitis.
    • The findings suggest that SPINK1-N34S is not a risk factor for chronic parotitis, despite similarities with pancreatitis.